This Article  • Full text  • PDF  • Correction  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in this journal  Topic Collections  • Choroidal Neovascularization  • Randomized Controlled Trial  • Prognosis/ Outcomes  • Alert me on articles by topic  Social Bookmarking   What's this?

I. Ophthalmic Findings From a Randomized Clinical Trial: Submacular Surgery Trials (SST) Group H Trial: SST Report No. 9

Submacular Surgery Trials Research Group^*

Arch Ophthalmol. 2004;122:1597-1611.

Objective  To present visual acuity findings and related outcomes from eyes of patients enrolled in a randomized trial conducted by the Submacular Surgery Trials (SST) Research Group (SST Group H Trial) to compare surgical removal vs observation of subfoveal choroidal neovascular lesions that were either idiopathic or associated with ocular histoplasmosis.

Methods  Eligible patients 18 years or older had subfoveal choroidal neovascularization (new or recurrent) that included a classic component on fluorescein angiography and best-corrected visual acuity of 20/50 to 20/800 in 1 eye ("study eye"). Patients were examined 3, 6, 12, and 24 months after enrollment to assess study outcomes and adverse events. Best-corrected visual acuity was measured by a masked examiner at the 24-month examination. A successful outcome was defined a priori as 24-month visual acuity better or no more than 1 line (7 letters) worse than at baseline.

Results  Among 225 patients enrolled (median visual acuity 20/100), 113 study eyes were assigned to observation and 112 to surgery. Forty-six percent of the eyes in the observation arm and 55% in the surgery arm had a successful outcome (success ratio, 1.18; 95% confidence interval, 0.89-1.56). Median visual acuity at the 24-month examination was 20/250 among eyes in the observation arm and 20/160 for eyes in the surgery arm. The prespecified subgroup of eyes with visual acuity worse than 20/100 at baseline (n = 92) had more successes with surgery; 31 (76%) of 41 eyes in the surgery arm vs 20 (50%) of 40 eyes in the observation arm examined at 24 months (success ratio, 1.53; 95% confidence interval, 1.08-2.16). Five (4%) of 111 eyes in the surgery arm subsequently had a rhegmatogenous retinal detachment. Twenty-seven (24%) of 112 initially phakic eyes in the surgery arm (none in the observation arm) had cataract surgery during follow-up, all among patients older than 50 years. Recurrent choroidal neovascularization developed by the 24-month examination in 58% of surgically treated eyes.

Conclusions  Overall, findings supported no benefit or a smaller benefit to surgery than the trial was designed to detect. Findings support consideration of surgery for eyes with subfoveal choroidal neovascularization and best-corrected visual acuity worse than 20/100 that meet other eligibility criteria for the SST Group H Trial. Other factors that may influence the treatment decision include the risks of retinal detachment, cataract among older patients, and recurrent choroidal neovascularization and the possibility that additional treatment will be required after submacular surgery.

*Authors: The Writing Committee for SST Research Group Report No. 9 served as authors and are responsible for its content.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLES

Surgical Removal vs Observation for Subfoveal Choroidal Neovascularization, Either Associated With the Ocular Histoplasmosis Syndrome or Idiopathic: II. Quality-of-Life Findings From a Randomized Clinical Trial: SST Group H Trial: SST Report No. 10
Submacular Surgery Trials Research Group
Arch Ophthalmol. 2004;122(11):1616-1628.
ABSTRACT | FULL TEXT  

Now That We Have the Results of the Subretinal Surgery Trials, How Do We Manage the Patient?
Harry W. Flynn, Jr and Ingrid U. Scott
Arch Ophthalmol. 2004;122(11):1705-1706.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Surgical Removal vs Observation for Idiopathic or Ocular Histoplasmosis Syndrome-Associated Subfoveal Choroidal Neovascularization: Vision Preference Value Scale Findings From the Randomized SST Group H Trial: SST Report No. 17
Submacular Surgery Trials Research Group
Arch Ophthalmol 2008;126:1626-1632.
ABSTRACT | FULL TEXT  

Photodynamic therapy with verteporfin in paediatric and young adult patients: long-term treatment results of choroidal neovascularisations
Lipski et al.
Br J Ophthalmol 2008;92:655-660.
ABSTRACT | FULL TEXT  

Two-year results of surgical removal of choroidal neovascular membranes related to non-age-related macular degeneration
Essex et al.
Br J Ophthalmol 2007;91:649-654.
ABSTRACT | FULL TEXT  

Predictors of Visual Outcome and Choroidal Neovascular Membrane Formation After Traumatic Choroidal Rupture
Ament et al.
Arch Ophthalmol 2006;124:957-966.
ABSTRACT | FULL TEXT  

Surgical Removal vs Observation for Subfoveal Choroidal Neovascularization, Either Associated With the Ocular Histoplasmosis Syndrome or Idiopathic: II. Quality-of-Life Findings From a Randomized Clinical Trial: SST Group H Trial: SST Report No. 10
Submacular Surgery Trials Research Group
Arch Ophthalmol 2004;122:1616-1628.
ABSTRACT | FULL TEXT  

Now That We Have the Results of the Subretinal Surgery Trials, How Do We Manage the Patient?
Flynn and Scott
Arch Ophthalmol 2004;122:1705-1706.
FULL TEXT